Optiva Inc. Extends Forbearance Period with Noteholders to Continue Negotiations with Noteholders and Third Parties regarding a Potential Transaction

Stock Information for MediPharm Labs Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MediPharm Labs Corp.

Optiva Receives Final Order Approving Arrangement with Qvantel
Optiva Announces Shareholder and Noteholder Approval of Going Private Transaction
Optiva Inc. Reports Third Quarter 2025 Financial Results
Optiva Announces Mailing of Meeting Materials and Receipt of Interim Order in Respect of Going Private Transaction
Qvantel and Optiva Join Forces to Drive the Next Evolution of AI-Powered BSS
Digitel Extends Partnership With Optiva to Power Next Phase of Growth
Optiva Inc. Reports Second Quarter 2025 Financial Results
Optiva Inc. enters into Support Agreement with Holders of Approximately 85% of Outstanding Senior Secured Notes to Provide 45-Day Period to Continue Negotiations with Noteholders and Third Parties regarding a Potential Transaction

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.